Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0050 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_0050 |
| Peptide Name | Deltorphan |
| PEPTIDE SEQUENCE (1-letter) | YAFDVVG |
| PEPTIDE SEQUENCE (3-letter) | Tyr-(D)Ala-Phe-Asp-Val-Val-Gly-NH2 |
| N-terminal modification | NA |
| C-terminal modification | Amide group is attached |
| Chemical modification | NA |
| Peptide Length | 7 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)O |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | NA |
| In vitro RESULT | NA |
| ANIMAL MODEL | C57BL6 mice |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | Intravenous |
| In vivo METHOD | Confocal microscopy |
| In vivo RESULT | Presence of engineered nano particles within the brain parenchyma with particular focus on hippocamp |
| ACTION | Opioid-derived peptides featured by specific helix-like conformation as possible ligands to engineer |
| TRANSPORT TYPE | NA |
| SUBCELLULAR LOCALISATION | CNS parenchyma |
| COMBINATION | Comined |
| PHYSICAL CONDITION | NA |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 32479916 |